{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:16:43Z","timestamp":1767889003405,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009096","name":"Firat University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009096","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.peptides.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T12:37:33Z","timestamp":1426336653000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effect of enalapril maleate on ghrelin levels in metabolic syndrome in rats"],"prefix":"10.1016","volume":"67","author":[{"given":"Bilge","family":"Aygen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Kucuksu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleyman","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Hanifi","family":"Ozercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2015.03.002_bib0200","doi-asserted-by":"crossref","unstructured":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med 1992;327:685\u201391.","DOI":"10.1056\/NEJM199209033271003"},{"key":"10.1016\/j.peptides.2015.03.002_bib0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gut.2004.038737","article-title":"Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin","volume":"54","author":"Asakawa","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.peptides.2015.03.002_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nut.2013.05.013","article-title":"Today's and yesterday's of pathophysiology: biochemistry of metabolic syndrome and animal models","volume":"30","author":"Aydin","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.peptides.2015.03.002_bib0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11010-012-1256-4","article-title":"Examination of the tissue ghrelin expression of rats with diet-induced obesity using radioimmunoassay and immunohistochemical methods","volume":"365","author":"Aydin","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.peptides.2015.03.002_bib0220","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1210\/jc.2006-2527","article-title":"Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome","volume":"92","author":"Barazzoni","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 5","key":"10.1016\/j.peptides.2015.03.002_bib0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2165\/00003495-198800355-00011","article-title":"Renal protective effect of long term antihypertensive therapy with enalapril","volume":"35","author":"Bauer","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.peptides.2015.03.002_bib0230","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/gerona\/59.5.B416","article-title":"Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats","volume":"59","author":"Carter","year":"2004","journal-title":"J Gerontol A: Biol Sci Med Sci"},{"key":"10.1016\/j.peptides.2015.03.002_bib0235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.prp.2008.10.002","article-title":"Ghrelin expression in normal kidney tissue and renal carcinomas","volume":"205","author":"Dagli","year":"2009","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.peptides.2015.03.002_bib0240","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jash.2014.01.006","article-title":"Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome","volume":"8","author":"Eizenberg","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.peptides.2015.03.002_bib0245","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1357-2725(02)00311-4","article-title":"The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome","volume":"35","author":"Engeli","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.peptides.2015.03.002_bib0250","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/neu.2009.1210","article-title":"The anti-inflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats","volume":"27","author":"Ersahin","year":"2010","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.peptides.2015.03.002_bib0255","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0026-0495(03)00274-9","article-title":"Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study","volume":"52","author":"Fagerberg","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.peptides.2015.03.002_bib0260","doi-asserted-by":"crossref","first-page":"e94373","DOI":"10.1371\/journal.pone.0094373","article-title":"Ghrelin protects against renal damages induced by angiotensin-II via an antioxidative stress mechanism in mice","volume":"9","author":"Fujimura","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.peptides.2015.03.002_bib0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03344083","article-title":"Ghrelin tissue distribution: comparison between gene and protein expression","volume":"29","author":"Ghelardoni","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.peptides.2015.03.002_bib0270","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","article-title":"The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans","volume":"87","author":"Gnanapavan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.peptides.2015.03.002_bib0275","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.regpep.2006.08.011","article-title":"Plasma ghrelin levels after two high-carbohydrate meals producing different insulin responses in patients with metabolic syndrome","volume":"138","author":"Heinonen","year":"2007","journal-title":"Regul Pept"},{"key":"10.1016\/j.peptides.2015.03.002_bib0280","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.peptides.2015.03.002_bib0285","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1073\/pnas.0802690105","article-title":"Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance","volume":"105","author":"Jayasooriya","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2015.03.002_bib0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3132\/dvdr.2004.010","article-title":"The metabolic syndrome: one step forward, two steps back","volume":"1","author":"Kim","year":"2004","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.peptides.2015.03.002_bib0295","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00012.2004","article-title":"Ghrelin: structure and function","volume":"85","author":"Kojima","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.peptides.2015.03.002_bib0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5001\/omj.2012.39","article-title":"Effects of losartan vs. enalapril on the markers of metabolic syndrome","volume":"27","author":"Kostapano","year":"2012","journal-title":"Oman Med J"},{"key":"10.1016\/j.peptides.2015.03.002_bib0305","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0895-7061(00)01279-6","article-title":"Weight reduction and pharmacologic treatment in obese hypertensives","volume":"14","author":"Masuo","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.peptides.2015.03.002_bib0310","doi-asserted-by":"crossref","first-page":"30H","DOI":"10.1016\/S0002-9149(03)00432-6","article-title":"Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease","volume":"91","author":"McFarlane","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.peptides.2015.03.002_bib0315","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/hy09t1.094234","article-title":"Angiotensin II and renal fibrosis","volume":"38","author":"Mezzano","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2015.03.002_bib0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-5793(00)02308-5","article-title":"Kidney produces a novel acylated peptide, ghrelin","volume":"486","author":"Mori","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.peptides.2015.03.002_bib0325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vph.2007.11.005","article-title":"Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes","volume":"48","author":"Oltman","year":"2008","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.peptides.2015.03.002_bib0330","doi-asserted-by":"crossref","first-page":"H1219","DOI":"10.1152\/ajpheart.00796.2011","article-title":"The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome","volume":"302","author":"Putnam","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2015.03.002_bib0335","doi-asserted-by":"crossref","first-page":"F423","DOI":"10.1152\/ajprenal.00124.2006","article-title":"Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats","volume":"292","author":"Sanchez-Lozada","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.peptides.2015.03.002_bib0340","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.intimp.2007.07.021","article-title":"Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats","volume":"8","author":"Santos","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.peptides.2015.03.002_bib0345","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.peptides.2015.03.002_bib0350","first-page":"323","article-title":"Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome","volume":"103","author":"Tabak","year":"2012","journal-title":"Minerva Med"},{"key":"10.1016\/j.peptides.2015.03.002_bib0355","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","article-title":"Metabolic syndrome and kidney disease: a systematic review and meta-analysis","volume":"6","author":"Thomas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.peptides.2015.03.002_bib0360","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.phrs.2012.06.006","article-title":"Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues","volume":"66","author":"Torsello","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.peptides.2015.03.002_bib0365","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tschop","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2015.03.002_bib0370","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/07853890600622192","article-title":"Low plasma ghrelin concentration is an indicator of the metabolic syndrome","volume":"38","author":"Ukkola","year":"2006","journal-title":"Ann Med"},{"key":"10.1016\/j.peptides.2015.03.002_bib0375","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00418-006-0165-6","article-title":"Immunohistochemical localization of ghrelin in rodent kidneys","volume":"126","author":"Yabuki","year":"2006","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.peptides.2015.03.002_bib0380","doi-asserted-by":"crossref","first-page":"e85785","DOI":"10.1371\/journal.pone.0085785","article-title":"Mechanisms of Ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.peptides.2015.03.002_bib0385","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MAJ.0b013e3181ec41ed","article-title":"Meta-analysis of the relationship between obestatin and ghrelin levels and the ghrelin\/obestatin ratio with respect to obesity","volume":"341","author":"Zhang","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.peptides.2015.03.002_bib0390","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2006.08.062","article-title":"Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma","volume":"552","author":"Zorad","year":"2006","journal-title":"Eur J Pharmacol"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978115000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978115000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T21:28:51Z","timestamp":1589491731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978115000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":39,"alternative-id":["S0196978115000601"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2015.03.002","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of enalapril maleate on ghrelin levels in metabolic syndrome in rats","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}